Autolus Therapeutics plc (AUTL) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
AUTL currently has 266M outstanding shares. with minimal authorized share overhang for future dilution. The company has diluted shareholders by 24.84% over the past 2 years through share issuances.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| May 14, 2026 |
10-Q filing | 266.1M shares outstanding |
270M | 0 |
| Mar 27, 2026 |
10-K filing | 266.1M shares outstanding |
270M | 0 |
| Nov 12, 2025 |
10-Q filing | 266.1M shares outstanding |
270M | 0 |
| Aug 12, 2025 |
10-Q filing | 266.1M shares outstanding |
270M | 0 |
| May 08, 2025 |
S-1 filing: This S-1 filing registers the offering of ADSs by selling securityholders, with each ADS representing one ordinary share. The filing also mentions ordinary shares to be outstanding after the offering, assuming the sale of all ADSs. |
320M | 0 |
| May 08, 2025 |
10-Q filing | 266.1M shares outstanding |
270M | 0 |
| Mar 20, 2025 |
POS AM filing: The prospectus is for a combination offering of ordinary shares, American Depositary Shares representing Ordinary Shares, debt securities, and warrants with an aggregate initial offering price not exceeding $300,000,000. |
270M | 0 |
| Mar 20, 2025 |
10-K filing | 255.2M shares outstanding |
260M | 0 |
| Nov 12, 2024 |
10-Q filing | 266.1M shares outstanding |
270M | 0 |
| Aug 08, 2024 |
10-Q filing | 266.0M shares outstanding |
270M | 0 |
| May 17, 2024 |
10-Q filing | 266.0M shares outstanding |
270M | 0 |
| Mar 21, 2024 |
10-K filing | 265.9M shares outstanding |
270M | 0 |
| Nov 09, 2023 |
10-Q filing | 174.0M shares outstanding |
170M | 0 |
| Mar 07, 2023 |
20-F filing | 173.1M shares outstanding |
170M | 0 |
| May 04, 2022 |
F-3 filing: This F-3 filing relates to the resale of up to 12,180,333 American Depositary Shares representing 12,180,333 ordinary shares of Autolus Therapeutics plc by selling securityholders. |
91M | 16M |
| Apr 15, 2022 |
F-3 filing: This F-3 filing relates to the resale of up to 21,250,917 American Depositary Shares representing 21,250,917 ordinary shares of Autolus Therapeutics plc by selling securityholders, including shares issuable upon exercise of outstanding warrants. |
91M | 3.9M |
| Mar 10, 2022 |
20-F filing | 90.9M shares outstanding |
91M | 0 |
| Aug 05, 2021 |
F-3 filing: The filing relates to a potential offering of Ordinary Shares, American Depositary Shares representing Ordinary Shares, and/or Debt Securities up to a total of $300,000,000. |
52M | 0 |
| Mar 04, 2021 |
20-F filing | 52.3M shares outstanding |
52M | 0 |
| Mar 03, 2020 |
20-F filing | 45.0M shares outstanding |
45M | 0 |